English court in landmark right-to-die ruling

An English judge ruled on Wednesday that a brain-damaged, minimally conscious woman should not be allowed to die, in a landmark case about the right to life-supporting treatment.

High judge Scott Baker said it was the first time an English court had been asked to consider whether such treatment should be withdrawn from a patient who was not in a persistent vegetative state but was minimally conscious.

The relatives of the patient, referred to only as M, had argued that she would not have wanted to live in her current condition and applied to the court asking for her food and water to be withdrawn.

Their lawyers argued that, eight years after suffering profound from viral encephalitis, she had shown no evidence of improvement.

The 52-year-old, who lives in a care home in northern England, is in a minimally -- just above a persistent vegetative state.

The for M's relatives said she was unable to consistently communicate or interact with her environment or with others, could not care for herself and suffered pain, distress and discomfort.

But a court-appointed lawyer representing the patient had argued against the relatives' application, saying that she was "otherwise clinically stable".

The local health authority also opposed the move.

In his ruling, Baker said: "The factor which does carry substantial weight, in my , is the preservation of life."

"I find that she does have some positive experiences and importantly that there is a reasonable prospect that those experiences can be extended by a planned programme of increased stimulation," he added.

The judge said all parties agreed that an existing "do not resuscitate" order should continue.

Law firm Irwin Mitchell, which represented M's relatives, said they were "deeply disappointed" but it was "very important" in clarifying that the High Court did have the power to decide on treatment for minimally conscious patients.

They added that the past eight years had been "heartbreaking" for M's family.

"They love her dearly and want only what is best for her, and it has been desperately difficult for them to make this application to court for treatment to be withdrawn," they said.

add to favorites email to friend print save as pdf

Related Stories

Court won't stop hormone replacement lawsuits

Oct 12, 2010

(AP) -- The Supreme Court won't reconsider a decision to reinstate more than 100 lawsuits filed by women who claimed that hormone replacement therapy caused breast cancer.

Court Denies Vonage Bid for Patent Case Retrial

May 04, 2007

A U.S. appeals court denies a request by Internet phone company Vonage Holdings that it order a retrial in the patent infringement case brought against it by Verizon Communications.

Recommended for you

Hormonal therapy for transsexualism safe and effective

10 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

14 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...